Details
| Stereochemistry | ABSOLUTE |
| Molecular Formula | C17H19N5O4 |
| Molecular Weight | 357.3639 |
| Optical Activity | UNSPECIFIED |
| Defined Stereocenters | 4 / 4 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
OC[C@H]1O[C@H]([C@H](O)[C@@H]1O)N2C=NC3=C2N=CN=C3NCC4=CC=CC=C4
InChI
InChIKey=MRPKNNSABYPGBF-LSCFUAHRSA-N
InChI=1S/C17H19N5O4/c23-7-11-13(24)14(25)17(26-11)22-9-21-12-15(19-8-20-16(12)22)18-6-10-4-2-1-3-5-10/h1-5,8-9,11,13-14,17,23-25H,6-7H2,(H,18,19,20)/t11-,13-,14-,17-/m1/s1
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Halogenation of N⁶-benzyladenosine decreases its cytotoxicity in human leukemia cells. | 2010-12 |
|
| Anticancer activity of natural cytokinins: a structure-activity relationship study. | 2010-08 |
|
| Characterization of pharmacologically active compounds that inhibit poliovirus and enterovirus 71 infectivity. | 2008-10 |
|
| Cytokinins in the bryophyte Physcomitrella patens: analyses of activity, distribution, and cytokinin oxidase/dehydrogenase overexpression reveal the role of extracellular cytokinins. | 2007-11 |
|
| Preparation, biological activity and endogenous occurrence of N6-benzyladenosines. | 2007-06-01 |
|
| Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents. | 2007-05-15 |
|
| Caspase inhibition and N6-benzyladenosine-induced apoptosis in HL-60 cells. | 2001 |
Patents
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
92208
Created by
admin on Mon Mar 31 18:19:05 GMT 2025 , Edited by admin on Mon Mar 31 18:19:05 GMT 2025
|
PRIMARY | |||
|
DTXSID901017782
Created by
admin on Mon Mar 31 18:19:05 GMT 2025 , Edited by admin on Mon Mar 31 18:19:05 GMT 2025
|
PRIMARY | |||
|
4294-16-0
Created by
admin on Mon Mar 31 18:19:05 GMT 2025 , Edited by admin on Mon Mar 31 18:19:05 GMT 2025
|
PRIMARY | |||
|
70423
Created by
admin on Mon Mar 31 18:19:05 GMT 2025 , Edited by admin on Mon Mar 31 18:19:05 GMT 2025
|
PRIMARY | |||
|
224-298-9
Created by
admin on Mon Mar 31 18:19:05 GMT 2025 , Edited by admin on Mon Mar 31 18:19:05 GMT 2025
|
PRIMARY | |||
|
0M6S0FAH3T
Created by
admin on Mon Mar 31 18:19:05 GMT 2025 , Edited by admin on Mon Mar 31 18:19:05 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
